# A Long Term Follow-Up Study for Asian Adult Patients With Attention Deficit Hyperactivity Disorder

> **NCT00969618** · PHASE3 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 211 (actual)

## Conditions studied

- Attention Deficit Hyperactivity Disorder

## Interventions

- **DRUG:** Atomoxetine

## Key facts

- **NCT ID:** NCT00969618
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 211 (ACTUAL)
- **Last updated:** 2012-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00969618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00969618, "A Long Term Follow-Up Study for Asian Adult Patients With Attention Deficit Hyperactivity Disorder". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00969618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*